Skip to main content

Gain Therapeutics, Inc.

GANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001819411

No open-market purchases or sales by Gain Therapeutics, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $17.4M in total; Greenlight Capital is the only superinvestor holding it.

13F holders, Q2 2026

Institutional positions in Gain Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
50
+8 vs. Q1 2026
Shares held
8.66M
+465.8K (+5.7%) vs. Q1 2026
Total value
$17.4M
+$1.57M (+9.9%) vs. Q1 2026
New holders
12
14 more added
Sold out
4
9 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting GANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 50 institutions
Q1 2021: 12 institutionsQ2 2021: 14 institutionsQ3 2021: 14 institutionsQ4 2021: 19 institutionsQ1 2022: 16 institutionsQ2 2022: 16 institutionsQ3 2022: 23 institutionsQ4 2022: 21 institutionsQ1 2023: 22 institutionsQ2 2023: 24 institutionsQ3 2023: 24 institutionsQ4 2023: 24 institutionsQ1 2024: 26 institutionsQ2 2024: 28 institutionsQ3 2024: 19 institutionsQ4 2024: 25 institutionsQ1 2025: 33 institutionsQ2 2025: 35 institutionsQ3 2025: 38 institutionsQ4 2025: 48 institutionsQ1 2026: 42 institutionsQ2 2026: 50 institutions
Value heldQ2 2026: $17.4M
Q1 2021: $15.0MQ2 2021: $8.95MQ3 2021: $6.65MQ4 2021: $5.71MQ1 2022: $4.75MQ2 2022: $3.87MQ3 2022: $3.95MQ4 2022: $3.78MQ1 2023: $5.54MQ2 2023: $5.68MQ3 2023: $4.95MQ4 2023: $5.05MQ1 2024: $7.04MQ2 2024: $3.89MQ3 2024: $2.40MQ4 2024: $3.94MQ1 2025: $5.07MQ2 2025: $6.49MQ3 2025: $7.70MQ4 2025: $25.9MQ1 2026: $15.8MQ2 2026: $17.4M
Institutions holding GANX and their total value by quarter
QuarterHoldersValue
Q2 202650$17.4M
Q1 202642$15.8M
Q4 202548$25.9M
Q3 202538$7.70M
Q2 202535$6.49M
Q1 202533$5.07M
Q4 202425$3.94M
Q3 202419$2.40M
Q2 202428$3.89M
Q1 202426$7.04M
Q4 202324$5.05M
Q3 202324$4.95M
Q2 202324$5.68M
Q1 202322$5.54M
Q4 202221$3.78M
Q3 202223$3.95M
Q2 202216$3.87M
Q1 202216$4.75M
Q4 202119$5.71M
Q3 202114$6.65M
Q2 202114$8.95M
Q1 202112$15.0M

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Gain Therapeutics, Inc.; share changes are against Q1 2026.

Institutions holding GANX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Marshall Wace, LLP1,923,546$3.90M0.00%+153,758+8.7%Added
Potomac Capital Management, Inc.946,400$1.92M1.41%−62,200−6.2%Reduced
Gsa Capital Partners LLP632,131$1.28M0.08%+319,664+102.3%Added
Cambridge Investment Research Advisors, Inc.568,645$1.15M0.00%00.0%Unchanged
DME Capital Management, LPSuperinvestorGreenlight Capital566,130$1.15M0.03%00.0%Unchanged
Jones Financial Companies LLLP608,592$1.07M0.00%−23,023−3.6%Reduced
Vanguard Capital Management LLC480,269$974.9K0.00%+80,383+20.1%Added
Geode Capital Management, LLC453,501$921.4K0.00%+6,159+1.4%Added
BlackRock, Inc.274,957$558.2K0.00%+49,911+22.2%Added
Vanguard Fiduciary Trust Co231,534$470.0K0.00%+1,555+0.7%Added
UBS Group AG215,012$436.5K0.00%−5,477−2.5%Reduced
Stratos Wealth Partners, LTD.200,000$406.0K0.00%+68,379+52.0%Added
Cresset Asset Management, LLC160,000$324.8K0.00%00.0%Unchanged
State Street Corp157,537$319.8K0.00%00.0%Unchanged
Citadel Advisors LLC154,524$313.7K0.00%+129,624+520.6%Added
Squarepoint Ops LLC136,359$276.8K0.00%+136,359New
Morgan Stanley125,972$255.7K0.00%−13,680−9.8%Reduced
LPL Financial LLC117,251$238.0K0.00%+13,000+12.5%Added
Northern Trust Corp97,013$196.9K0.00%−16,984−14.9%Reduced
Susquehanna International Group, LLP78,206$158.8K0.00%−353,061−81.9%Reduced
Commonwealth Equity Services, LLC58,456$118.7K0.00%+28,753+96.8%Added
Jane Street Group, LLC55,628$112.9K0.00%−161,255−74.4%Reduced
XTX Topco Ltd55,294$112.2K0.00%+55,294New
Prelude Capital Management, LLC35,820$72.7K0.01%00.0%Unchanged
Benedict Financial Advisors Inc35,000$71.0K0.01%+19,500+125.8%Added
Bridgeway Capital Management, LLC30,004$60.9K0.00%00.0%Unchanged
Apollon Wealth Management, LLC26,500$53.8K0.00%00.0%Unchanged
Virtu Financial LLC21,015$43.0K0.00%+10,330+96.7%Added
Oliver Luxxe Assets LLC20,250$41.1K0.01%00.0%Unchanged
Vanguard Global Advisers, LLC18,376$37.3K0.00%00.0%Unchanged
HighTower Advisors, LLC17,174$34.9K0.00%+17,174New
Wealthspire Advisors, LLC16,900$34.3K0.00%00.0%Unchanged
Sandhill Capital Partners LLC15,400$31.3K0.00%00.0%Unchanged
Wealth Enhancement Advisory Services, LLC17,056$30.7K0.00%+1,500+9.6%Added
HB Wealth Management, LLC12,783$25.9K0.00%+12,783New
Two Sigma Securities, LLC12,739$25.9K0.00%+12,739New
Millington Financial Advisors, LLC15,000$25.6K0.01%00.0%Unchanged
Harbour Investments, Inc.10,745$21.8K0.00%+10,745New
GWM Advisors LLC10,600$21.5K0.00%00.0%Unchanged
Mercer Global Advisors Inc10,000$20.3K0.00%+10,000New
Sanctuary Advisors, LLC10,000$20.3K0.00%+10,000New
Wells Fargo & Company9,400$19.1K0.00%−1,650−14.9%Reduced
Tower Research Capital LLC (TRC)8,321$16.9K0.00%+2,815+51.1%Added
Group One Trading, L.P.3,808$7.73K0.00%−2,596−40.5%Reduced
Advisor Group Holdings, Inc.2,000$4.06K0.00%+2,000New
SRS Capital Advisors, Inc.1,700$3.45K0.00%+1,700New
JPMorgan Chase & Co1,700$3.37K0.00%00.0%Unchanged
Barclays PLC1,352$2.75K0.00%+1,352New
Caitong International Asset Management Co., Ltd165$3350.00%+165New
Larson Financial Group LLC10$200.00%00.0%Unchanged
Schonfeld Strategic Advisors LLC0$00.00%−24,500−100.0%Sold out
Simplex Trading, LLC0$00.00%−13,439−100.0%Sold out
Kestra Advisory Services, LLC0$00.00%−12,000−100.0%Sold out
Citigroup Inc0$00.00%−1−100.0%Sold out